Related Experiment Video
Updated: Aug 25, 2025
09:04
Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation
Published on: September 7, 2010
11.7K
Sialidase Inhibitors with Different Mechanisms
Joseph M Keil1, Garrett R Rafn1, Isaac M Turan1
1Department of Chemistry, Chemical and Biomedical Engineering and Center for Gene Regulation in Health and Disease (GRHD), Cleveland State University, Cleveland, Ohio 44115, United States.
Journal of Medicinal Chemistry
|October 17, 2022
Summary
Sialidase inhibitors, including transition-state analogues and natural products, offer promising strategies for understanding enzyme function and developing new therapeutics. This perspective reviews diverse inhibitor types and their potential applications.
Area of Science:
- Enzymology
- Biochemistry
- Drug Discovery
Background:
- Sialidases (neuraminidases) are enzymes critical for biological pathways, catalyzing the removal of sialic acid from molecules.
- Modulating sialidase activity through inhibition is crucial for understanding enzyme function and developing therapeutic interventions.
Purpose of the Study:
- To provide a comprehensive overview of various sialidase inhibitors and their mechanisms of action.
- To discuss the current activities and future potential of different classes of sialidase inhibitors.
Main Methods:
- Review of existing literature on sialidase inhibitors.
- Categorization of inhibitors based on their mechanisms: transition-state analogues, mechanism-based inhibitors, suicide substrates, product analogues, and natural products.
Main Results:
- Identified and described multiple classes of sialidase inhibitors, including clinically used drugs like oseltamivir and zanamivir.
- Highlighted the development of novel inhibitors such as difluoro-sialic acids and fluorinated quinone methides.
- Acknowledged the inhibitory potential of natural products against viral, bacterial, and human sialidases.
Conclusions:
- Sialidase inhibitors represent a diverse and evolving field with significant therapeutic potential.
- Continued research into novel inhibitor designs and natural product sources is essential for advancing sialidase-targeted therapies.
Related Concept Videos
01:30Enzyme Inhibition
79.0K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
79.0K
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.0K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.0K
01:23Dipeptidyl Peptidase 4 Inhibitors
234
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
234
01:27Combined Effects of Drugs: Synergism
4.5K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.5K
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
635
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
635
01:17Oral Hypoglycemic Agents: Sulfonylureas
290
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
290